Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:04 pm Purchase | 2024-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON | EcoR1 Capital, LLC | 1,981,003 7.700% | 583,334 (+41.74%) | Filing History |
| 2024-12-09 4:04 pm Purchase | 2024-12-02 | 13G | Eton Pharmaceuticals, Inc. ETON | EcoR1 Capital, LLC | 1,397,669 5.400% | 1,397,669 (New Position) | Filing History |
| 2024-09-12 4:05 pm Purchase | 2024-09-09 | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,722,500 10.340% | 197,613 (+7.83%) | Filing History |
| 2024-04-30 07:00 am Sale | 2024-04-26 | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW INC. HROW | 0 0.000% | -1,982,000 (Position Closed) | Filing History |
| 2024-02-09 4:05 pm Purchase | 2023-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,524,887 9.840% | 354,887 (+16.35%) | Filing History |
| 2023-01-20 4:53 pm Sale | 2022-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,170,000 8.580% | -215,000 (-9.01%) | Filing History |
| 2022-01-28 4:05 pm Sale | 2021-04-12 | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW INC. HROW | 1,982,000 8.100% | -1,518,000 (-43.37%) | Filing History |
| 2022-01-24 4:05 pm Sale | 2021-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,385,000 9.690% | -1,307,700 (-35.41%) | Filing History |
| 2021-06-17 4:40 pm Purchase | 2020-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 3,692,700 15.070% | 52,700 (+1.45%) | Filing History |
| 2021-02-16 5:02 pm Sale | 2021-02-04 | 13G | Eton Pharmaceuticals, Inc. ETON | APPEL PETER A | 1,084,329 4.480% | -165,000 (-13.21%) | Filing History |